Smith Mark Burnham 4
4 · Finch Therapeutics Group, Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Smith Mark Burnham
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-18+595,402→ 595,402 totalExercise: $17.00Exp: 2031-03-17→ Common Stock (595,402 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 18, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.